[18F]FES PET/CT
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for [18F]FES PET/CT, covering 2024-08-21 to 2025-08-08. Get the full timeline:
Most recent: Clinical Trial Update: [18F]FES PET/CT in Endocrine Refractory Breast Cancer [Phase 2]